English English
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Interactive Webinars

Long-term Outcomes: Durability and Safety

Presented by Prof. Margareth C. Ozelo, MD, PhD

Update on Efficacy of Clinical Trials

Presented by Guy Young, MD

Obstacles and Opportunities

Presented by Frank W.G. Leebeek, MD, PhD

Adeno-Associated Viral (AAV) Vector Gene Therapy: Application to Hemophilia

Presented by Barbara A. Konkle, MD

Patient Support, Patient Counseling, and Monitoring

Presented by Lindsey A. George, MD

Gene Therapy for Treatment of Hemophilia: An Introduction to Adeno-Associated Viral Vector Gene Transfer

Presented by Johnny Mahlangu, BSc, MBBCh, MMed, FCPath

Gene Therapy for FVIII

Presented by K. John Pasi, MB ChB, PhD, FRCP, FRCPath, FRCPC

Gene Therapy for Treatment of Hemophilia: Common Concerns in Gene Therapy

Presented by Thierry VandenDriessche, PhD

Back To Top
Image

Please enable the javascript to submit this form

About

Supported by educational grants from Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, and uniQure, Inc.

Essential SSL